Estimation of chicken intake using metabolomics derived markers

Files in This Item:
File Description SizeFormat 
Yin_et_al_2017.pdf768.3 kBAdobe PDFDownload
Title: Estimation of chicken intake using metabolomics derived markers
Authors: Yin, Xiaofei
Gibbons, Helena
Rundle, Milena
McNulty, Breige A.
Nugent, Anne P.
Gibney, Michael J.
Brennan, Lorraine
et al.
Permanent link: http://hdl.handle.net/10197/9340
Date: 1-Oct-2017
Abstract: Background: Improved assessment of meat intake using metabolomics derived markers can provide objective data and could be helpful in clarifying proposed associations between meat intake and health.Objective: The objective was to identify novel markers of chicken intake using a metabolomics approach, and use markers to determine intake in an independent cohort. Methods: Ten participants (age, 62 y; BMI, 28.25 Kg/m2) in NutriTech Food Intake Study (NCT01684917) consumed increased amounts of chicken from 88 to 290 g/day over three weeks. Urine and blood samples were analyzed by NMR and MS, respectively. Multivariate data analysis was performed to identify markers associated with chicken intake. A calibration curve was built based on dose response association using NutriTech data. Bland and Altman analysis evaluated the agreement between reported and calculated chicken intake in National Adult Nutrition Survey (NANS) cohort. Results: Multivariate data analysis of postprandial and fasting urine samples collected in NutriTech revealed good discrimination between high (290 g/day) and low (88 g/day)  chicken intakes. Urinary metabolite profiles showed differences in metabolite levels between low and high chicken intakes. Examining metabolite profiles revealed guanidoacetate significantly increased from 1.47 to 3.66 mmol/L following increasing chicken intake from 88 to 290 g/day (P < 0.01). Using a calibration curve developed from NutriTech study, chicken intake was calculated in NANS, where chicken consumers had higher guanidoacetate excretion (0.70 mmol/L) than non-consumers (0.47 mmol/L) (P < 0.01). Bland and Altman analysis revealed good agreement between reported and calculated intakes with a bias of -30.2g/day. Plasma metabolite analysis demonstrated that 3-methylhistidine (3-Meth-His) was a more suitable indicator of chicken intake compared with 1-methylhistidine (1-Meth-His). Conclusions: Guanidoacetate was successfully identified and confirmed as a marker of chicken intake, and importantly its measurement in fasting urine samples could be used to determine chicken intake in a free-living population.
Funding Details: Department of Agriculture, Food and the Marine
European Commission - Seventh Framework Programme (FP7)
European Research Council
Type of material: Journal Article
Publisher: Oxford University Press
Copyright (published version): 2017 Oxford University Press
Keywords: MetabolomicsDietary markersGuanidoacetateEstimated chicken intake3-methylhistidine
DOI: 10.3945/jn.117.252197
Language: en
Status of Item: Peer reviewed
Appears in Collections:Institute of Food and Health Research Collection
Agriculture and Food Science Research Collection

Show full item record

SCOPUSTM   
Citations 50

1
Last Week
0
Last month
checked on Aug 17, 2018

Google ScholarTM

Check

Altmetric


This item is available under the Attribution-NonCommercial-NoDerivs 3.0 Ireland. No item may be reproduced for commercial purposes. For other possible restrictions on use please refer to the publisher's URL where this is made available, or to notes contained in the item itself. Other terms may apply.